ArticleJournal of the National Cancer Institute2023

RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.

François Bertucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.